About the Journal

Editor-in-Chief
Giovanna Muscogiuri, MD, PhD
Full Professor of Medicine (joint position), University of Tucson, Arizona, USA
Assistant Professor in Endocrinology at University of Naples Federico II, Naples, Italy  Read more...

ISSN-print: 1923-2861  |  ISSN-online: 1923-287X  |  Bimonthly  | Open Access  | Aims and Scope
Indexed and covered by: Scopus, Chemical Abstract (CA); EBSCO; Worldcat; Google Scholar; PubMed: selected citations only (NIH supported articles); Clarivate Analytics Emerging Sources Citation Index (ESCI-Web of Science) 
JCR Impact Factor (2024): 0.6; Scopus CiteScore (2024): 0.9
Journal archiving and digital preservation: Portico

Article Publishing Charge (APC)
For submissions from August 1st, 2025, there will be no Article Publishing Charge (APC).


Call for Papers: Special Issue on “Thyroid Management 2.0”

The Journal of Endocrinology and Metabolism is pleased to announce a forthcoming Special Issue entitled “Thyroid Management 2.0”, dedicated to the latest advances, technologies, and clinical strategies transforming the field of thyroid disease diagnosis and management.

Guest Editor
Cristina Luongo, MD, Assistant Professor
Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy

About the Special Issue
Thyroid disorders affect hundreds of millions of people globally and remain a major focus within endocrine care. With the advent of precision medicine, artificial intelligence, novel therapeutics, and updated clinical guidelines, the management of thyroid conditions is entering a new era—what we term "Thyroid Management 2.0."

This Special Issue aims to present cutting-edge research and comprehensive reviews that reflect this evolution. We welcome submissions that address, but are not limited to, the following topics:

1) Innovations in thyroid imaging and diagnostics; 2) Artificial intelligence and digital health tools in thyroidology; 3) Personalized treatment approaches for thyroid cancer; 4) Advances in molecular and genetic understanding of thyroid disease; 5) Updates in management of hypothyroidism, hyperthyroidism, and thyroiditis; 6) Autoimmune thyroid disorders and immune modulation; 7) Patient-reported outcomes and quality of life studies; 8) Long-term surveillance and follow-up strategies.

Submission Guidelines
Submission Deadline: December 31, 2025 
Article Types Accepted: Original Research, Review Articles, Clinical Trials, Case Reports, Meta-analyses, Editorials

Authors should submit their manuscripts through our online submission system and clearly indicate in the Cover Letter that the manuscript is for consideration in the Special Issue "Thyroid Management 2.0." All submissions will undergo standard peer review in accordance with the journal’s policies.


Current Issue

Vol. 15, No. 4, Oct 2025
Published: 2025-10-05

Review

  • DOI: https://doi.org/10.14740/jem1550

Original Article

  • Effect of Imeglimin on Microalbuminuria and Serum Vitamin B12 Concentration in Japanese Patients With Type 2 Diabetes

    Yukiyoshi Sada, Tomohiko Kurosu, Shutaro Uchiyama, Shohei Mihara, Masakatsu Sone, Yasushi Tanaka
    130-136
    DOI: https://doi.org/10.14740/jem1537
  • DOI: https://doi.org/10.14740/jem1545
  • DOI: https://doi.org/10.14740/jem1546
  • The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin

    Animesh Maiti, Arun Kumar Pandey, Shailja Kale, Tirthankar Mukherjee, Amitabh Biswas, Salil Kumar Pal, Ramanan A, J.P. Vignesh, R. Navin, Lakshmana Kumar Nelakuditi, Chandrashekhar Gillurkar, Biplab Bandyopadhyaya, Nilesh Detroja, Rohan Narayan Kesarkar, Ashish Prasad, Abhijit Pednekar
    153-160
    DOI: https://doi.org/10.14740/jem1055
  • Link Between Immune Dysregulation in COVID-19 and Beta-Cell Dysfunction

    Victoria Tsvetanova Tsvetkova, Malvina Svilenova Todorova, Katya Nikolova Todorova
    161-180
    DOI: https://doi.org/10.14740/jem1547
View All Issues